Location History:
- Foster City, CA (US) (2018)
- San Mateo, CA (US) (2013 - 2024)
Company Filing History:
Years Active: 2013-2025
Title: The Innovative Contributions of Robert G. Strickley
Introduction
Robert G. Strickley is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for viral infections. With a total of 12 patents to his name, Strickley's work has had a substantial impact on medical science.
Latest Patents
Among his latest patents is the invention related to crystalline forms of tenofovir alafenamide. This invention focuses on novel crystalline forms of salts and/or co-crystals of tenofovir alafenamide, along with pharmaceutical formulations and therapeutic uses for treating viral infections. Another notable patent involves compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections. This disclosure provides a composition that includes Compound 1, or a pharmaceutically acceptable salt thereof, cyclodextrin, and, optionally, pH adjusting agents.
Career Highlights
Strickley has worked with several esteemed companies throughout his career, including Gilead Sciences, Inc. and Amygdala Neurosciences, Inc. His work in these organizations has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Carina E. Cannizzaro and Michael Graupe. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Robert G. Strickley exemplifies the spirit of innovation in the field of pharmaceuticals. His contributions through patents and collaborations have paved the way for new treatments that address critical health challenges.